Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Parkinson's Disease

Free Subscription Articles published in Brain Res Retrieve available abstracts of 64 articles: HTML format

Single Articles

December 2025
1. HUA YH, Huang XY, Ma JJ, Wu J, et al
   Ezetimibe mitigates microglial activation in Parkinson's disease via TLR4/JNK pathway inhibition: evidence from network pharmacology and experimental validation.
   Brain Res. 2025 Dec 17:150116. doi: 10.1016/j.brainres.2025.150116.
   PubMed     Abstract available
   
   
   November 2025
2. LI Y, Liu Y, Lin Z, Wei Q, et al
   Aerobic exercise modulates plasma oxidized lipid metabolites and neurotransmitters in Parkinson's disease motor subtypes.
   Brain Res. 2025;1869:150038.
   PubMed     Abstract available
   
   
   
3. CHOI H, Hwang SB, Cho HY, Ahn S, et al
   Memantine modulates neuroinflammation and motor coordination in a Parkinson's disease model.
   Brain Res. 2025 Nov 4:150034. doi: 10.1016/j.brainres.2025.150034.
   PubMed     Abstract available
   
   
   October 2025
4. HUANG L, Shu J, Chen Q, Li J, et al
   The underlying mechanism of Erbai decoction on Parkinson's disease rats: a behavioral and pathological study.
   Brain Res. 2025 Oct 31:150008. doi: 10.1016/j.brainres.2025.150008.
   PubMed     Abstract available
   
   
   
5. MANNE M, Taksande B, Umekar M, Vinchurney M, et al
   The traffic jam hypothesis: Unravelling cellular dysfunctions in Parkinsonism diseases.
   Brain Res. 2025 Oct 21:150002. doi: 10.1016/j.brainres.2025.150002.
   PubMed     Abstract available
   
   
   
6. HAJARE S, Kulkarni YA
   Parkinson's disease and the gut-brain connection: unveiling pathways, mechanisms and promising therapies.
   Brain Res. 2025 Oct 4:149975. doi: 10.1016/j.brainres.2025.149975.
   PubMed     Abstract available
   
   
   September 2025
7. KENTROS M, Follett J, Subrahmanian N, Chairmandurai A, et al
   Regulation of LRRK2 activity by metabolic stress and heavy metal exposure.
   Brain Res. 2025;1863:149785.
   PubMed     Abstract available
   
   
   
8. YANG B, Jiang T, Li Y, Liu Y, et al
   Changes in gut microbiota and plasma metabolites in Parkinson's disease patients with pain as analyzed by 16S rDNA sequencing and LC-MS.
   Brain Res. 2025 Sep 12:149948. doi: 10.1016/j.brainres.2025.149948.
   PubMed     Abstract available
   
   
   
9. ZHUANG Z, Zhang L, Wang Y
   USP2 alleviates MPP(+)-induced neuronal injury by stabilizing FOXC1 in SK-N-SH cells.
   Brain Res. 2025;1862:149689.
   PubMed     Abstract available
   
   
   
10. CAI L, Ding Y, Tekreeti AA, Li F, et al
    Remote ischemic conditioning as a potential therapy for Parkinson's Disease: Inhibiting TLR4-Driven neuroinflammation and oxidative damage.
    Brain Res. 2025 Sep 1:149920. doi: 10.1016/j.brainres.2025.149920.
    PubMed     Abstract available
    
    
    August 2025
11. XU L, Deng J, Xiong W, Li L, et al
    Macrophages in the dCLN are required for alpha-synuclein proteostasis in A53T PD model mice.
    Brain Res. 2025;1860:149692.
    PubMed     Abstract available
    
    
    July 2025
12. CHEN H, Ding H, Huang D, Wu S, et al
    GBE1 alleviates MPTP-induced PD symptoms in mice by enhancing glycolysis and oxidative phosphorylation.
    Brain Res. 2025;1859:149663.
    PubMed     Abstract available
    
    
    
13. AUNG TL, Kan Y, Aung YW, Shi X, et al
    Meta-analysis of long non-coding RNA expression profile in Parkinson's disease.
    Brain Res. 2025 Jul 14:149838. doi: 10.1016/j.brainres.2025.149838.
    PubMed     Abstract available
    
    
    
14. AQUINO YC, Pedrao LF, Moreira TS, Falquetto B, et al
    Testosterone modulates respiratory control but does not exert neuroprotective effects in a Parkinson's disease model.
    Brain Res. 2025;1864:149829.
    PubMed     Abstract available
    
    
    
15. SI Y, Yan S, Li X, Ding W, et al
    P2X7R activation promotes ferroptosis in dopaminergic neurons via NF-kappaB signaling pathway in vitro and in vivo models of MPP(+)/MPTP-induced Parkinson's disease.
    Brain Res. 2025 Jul 8:149824. doi: 10.1016/j.brainres.2025.149824.
    PubMed     Abstract available
    
    
    June 2025
16. XIE G, Yang Y, Zhang X, Chen Y, et al
    Tris (1,3-dichloro-2-propyl) phosphate (TDCPP) aggravates Parkinson's disease neurotoxicity through ferroptosis-related oxidative stress and neuroinflammation.
    Brain Res. 2025 Jun 25:149805. doi: 10.1016/j.brainres.2025.149805.
    PubMed     Abstract available
    
    
    May 2025
17. FOROOZANMEHR B, Hemmati MA, Yaribeygi H, Karav S, et al
    Parkinson's disease and brain insulin signaling: Mechanisms and potential role of GLP-1 mimetics.
    Brain Res. 2025;1862:149738.
    PubMed     Abstract available
    
    
    
18. KATRIB C, Naidji C, Devos D, Timmerman K, et al
    Texture features of T2w magnetic resonance imaging mirror tissue changes in Parkinson's disease models.
    Brain Res. 2025 May 19:149717. doi: 10.1016/j.brainres.2025.149717.
    PubMed     Abstract available
    
    
    
19. KAUR J, Sharma V, Khan H, Singh S, et al
    Intersecting molecular pathways in Synucleinopathies and Amyloidogenesis: Exploring shared mechanisms and therapeutic potential.
    Brain Res. 2025;1855:149568.
    PubMed     Abstract available
    
    
    
20. HYDERI Z, Farhana M S, Singh TP, Ravi AV, et al
    Therapeutic Targeting of Autosomal Parkinson's Disease by Modulation of Leucine-Rich Repeat Kinase 2 (LRRK2) Protein.
    Brain Res. 2025;1860:149674.
    PubMed     Abstract available
    
    
    
21. WANG HY, Liang Z, Yan Z, Liu Y, et al
    Neural mechanisms linking sleep disturbances to motor and cognitive impairments in Parkinson's disease: Evidence from resting-state and task-based fNIRS.
    Brain Res. 2025;1860:149681.
    PubMed     Abstract available
    
    
    April 2025
22. USMAN S, Mondal AC
    Menopause triggers microglia-associated neuroinflammation in Parkinson's disease.
    Brain Res. 2025 Apr 16:149649. doi: 10.1016/j.brainres.2025.149649.
    PubMed     Abstract available
    
    
    
23. COTRIN JC, Dos Santos Junior GC, Cadaxo AS, Pereira JS, et al
    Plasma and urinary metabolomic signatures differentiate genetic and idiopathic Parkinson's disease.
    Brain Res. 2025 Apr 7:149625. doi: 10.1016/j.brainres.2025.149625.
    PubMed     Abstract available
    
    
    March 2025
24. LIU Y, Cheng Y, Chen T, Wang J, et al
    Basal ganglia connectivity and network asymmetry in Parkinson's disease: A resting-state fMRI study.
    Brain Res. 2025 Mar 18:149576. doi: 10.1016/j.brainres.2025.149576.
    PubMed     Abstract available
    
    
    
25. MANGANOTTI P, Liccari M, Maria Isabella Lombardo T, Della Toffola J, et al
    Effect of a single session of transcranial pulse stimulation (TPS) on resting tremor in patients with Parkinson's disease.
    Brain Res. 2025;1850:149405.
    PubMed     Abstract available
    
    
    February 2025
26. KUMAR D, Kumar R, Janrao S, Sharma V, et al
    Treadmill exercise mitigates rotenone-induced neuroinflammation and alpha-synuclein level in a mouse model of Parkinson's disease.
    Brain Res. 2025;1854:149540.
    PubMed     Abstract available
    
    
    
27. SAMSON JS, Rajagopal K, Parvathi VD
    Outlook of SNCA (alpha-synuclein) transgenic fly models in delineating the sequel of mitochondrial dysfunction in Parkinson's disease.
    Brain Res. 2025;1852:149505.
    PubMed     Abstract available
    
    
    
28. KOOB AO, Shaked GM, Bender A, Bisquertt A, et al
    Corrigendum to "Neurogranin binds alpha-synuclein in the human superior temporal cortex and interaction is decreased in Parkinson's disease" [Brain Res. 1591 (2014) 102-110].
    Brain Res. 2025 Feb 12:149504. doi: 10.1016/j.brainres.2025.149504.
    PubMed    
    
    
    
29. DUTTA A, Roy R, Pandey M, Chhetry S, et al
    Arsenic-induced mice model of Parkinson's disease: Revealing the neurotoxicity of arsenic through mitochondrial complexes inhibition and dopaminergic neurodegeneration in the substantia nigra region of brain.
    Brain Res. 2025;1851:149493.
    PubMed     Abstract available
    
    
    January 2025
30. USMAN JS, Wong TW, Ng SSM
    Effects of transcranial direct current stimulation combined with concurrent dual-task walking on mobility, gait, and cognitive outcomes: A systematic review.
    Brain Res. 2025;1846:149255.
    PubMed     Abstract available
    
    
    December 2024
31. SHARMA R, Thirugnanasambandam N
    Theta-Gamma Decoupling - A neurophysiological marker of impaired reward processing in Parkinson's disease.
    Brain Res. 2024 Dec 19:149406. doi: 10.1016/j.brainres.2024.149406.
    PubMed     Abstract available
    
    
    
32. WEN B, Li X, Xu J, He Y, et al
    The mechanism of SiJunZi decoction in the treatment of Parkinson's disease.
    Brain Res. 2024;1850:149397.
    PubMed     Abstract available
    
    
    August 2024
33. BHARDWAJ K, Jha A, Roy A, Kumar H, et al
    The crucial role of VPS35 and SHH in Parkinson's disease: Understanding the mechanisms behind the neurodegenerative disorder.
    Brain Res. 2024;1845:149204.
    PubMed     Abstract available
    
    
    
34. LI Y, Wang Q, Zhang X, Zheng R, et al
    Characterization of D1R and D2R neuronal subpopulations in the globus pallidus interna: Implications for Parkinson's disease pathogenesis.
    Brain Res. 2024 Aug 19:149174. doi: 10.1016/j.brainres.2024.149174.
    PubMed     Abstract available
    
    
    
35. LI J, Xu Y, Liu X, Yang F, et al
    Cortical morphological alterations in cognitively normal Parkinson's disease with severe hyposmia.
    Brain Res. 2024;1844:149150.
    PubMed     Abstract available
    
    
    
36. SHAH S, Pushpa Tryphena K, Singh G, Kulkarni A, et al
    Neuroprotective role of Carvacrol via Nrf2/HO-1/NLRP3 axis in Rotenone-induced PD mice model.
    Brain Res. 2024;1836:148954.
    PubMed     Abstract available
    
    
    July 2024
37. CHATTERJEE A, Mohapatra J, Sharma M, Jha A, et al
    A novel selective NLRP3 inhibitor shows disease-modifying potential in animal models of Parkinson's disease.
    Brain Res. 2024 Jul 27:149129. doi: 10.1016/j.brainres.2024.149129.
    PubMed     Abstract available
    
    
    
38. STATZ M, Weber H, Schleuter F, Kober M, et al
    Subthalamic nucleus deep brain stimulation induces functional deficits in norepinephrinergic neurotransmission in a Parkinson's disease model.
    Brain Res. 2024 Jul 23:149128. doi: 10.1016/j.brainres.2024.149128.
    PubMed     Abstract available
    
    
    June 2024
39. JIN M, Ye K, Hu D, Chen J, et al
    Identification of diagnose related therapeutic targets of Danggui buxue decoction in Parkinson's disease.
    Brain Res. 2024 Jun 29:149097. doi: 10.1016/j.brainres.2024.149097.
    PubMed     Abstract available
    
    
    
40. MA LY, Jia B, Geng H, Liang J, et al
    Poly(rC)-binding protein 1 alleviates neurotoxicity in 6-OHDA-induced SH-SY5Y cells and modulates glial cells in neuroinflammation.
    Brain Res. 2024;1832:148863.
    PubMed     Abstract available
    
    
    May 2024
41. LI L, Chen Z, Hao C
    Neuroprotective effects of polyphyllin VI against rotenone-induced toxicity in SH-SY5Y cells.
    Brain Res. 2024;1830:148824.
    PubMed     Abstract available
    
    
    April 2024
42. HOFFMEISTER JD, Broadfoot CK, Schaen-Heacock NE, Lechner SA, et al
    Vocal and tongue exercise in early to mid-stage Parkinson disease using the Pink1-/- rat.
    Brain Res. 2024 Apr 27:148958. doi: 10.1016/j.brainres.2024.148958.
    PubMed     Abstract available
    
    
    
43. CANSIZ D, Unal I, Gani Surmen M, Surmen S, et al
    Gentisic acid exerts neuroprotective effects in neurotoxin-induced Parkinson's disease model in zebrafish: Cross-talk between pathways related with neurodegeneration in the gut-brain axis.
    Brain Res. 2024 Apr 19:148952. doi: 10.1016/j.brainres.2024.148952.
    PubMed     Abstract available
    
    
    March 2024
44. ROSTAMI Z, Salari M, Mahdavi S, Etemadifar M, et al
    Abnormal multisensory temporal discrimination in Parkinson's disease.
    Brain Res. 2024 Mar 30:148901. doi: 10.1016/j.brainres.2024.148901.
    PubMed     Abstract available
    
    
    
45. MANSOUR HM, Mohamed AF, Khattab MM, El-Khatib AS, et al
    Unveiling the therapeutic prospects of EGFR inhibition in rotenone-mediated parkinsonism in rats: Modulation of dopamine D3 receptor.
    Brain Res. 2024;1834:148893.
    PubMed     Abstract available
    
    
    
46. GENG C, Tan L, Chenchen
    Neuropsychiatric symptoms profile and markers of Alzheimer disease-type pathology in patients with Lewy body dementias.
    Brain Res. 2024 Mar 20:148881. doi: 10.1016/j.brainres.2024.148881.
    PubMed     Abstract available
    
    
    December 2023
47. FLORES AJ, Bartlett MJ, Seaton BT, Samtani G, et al
    Antagonism of kappa opioid receptors accelerates the development of L-DOPA-induced dyskinesia in a preclinical model of moderate dopamine depletion.
    Brain Res. 2023;1821:148613.
    PubMed     Abstract available
    
    
    November 2023
48. SMIT RD, Ghosh B, Campion TJ 3rd, Stingel R, et al
    STAT3 protects dopaminergic neurons against degeneration in animal model of Parkinson's disease.
    Brain Res. 2023;1824:148691.
    PubMed     Abstract available
    
    
    
49. LIU X, Liu X, Liu Y, Yang B, et al
    Utility of serum neurofilament light chain and glial fibrillary acidic protein as diagnostic biomarkers of freezing of gait in Parkinson's disease.
    Brain Res. 2023;1822:148660.
    PubMed     Abstract available
    
    
    
50. ZHANG L, Guo Y, Liu J, Li L, et al
    Transcranial direct current stimulation of the prefrontal cortex improves depression-like behaviors in rats with Parkinson's disease.
    Brain Res. 2023 Nov 1:148649. doi: 10.1016/j.brainres.2023.148649.
    PubMed     Abstract available
    
    
    October 2023
51. ISMAEL S, Colvin RA, Lee D
    Activation of cyclic AMP signaling pathway in dopaminergic neurons rescues locomotion defects in a Drosophila larval model of Parkinson's disease.
    Brain Res. 2023 Oct 20:148641. doi: 10.1016/j.brainres.2023.148641.
    PubMed     Abstract available
    
    
    September 2023
52. YIN N, Wang H, Wang Z, Feng K, et al
    A study of brain networks associated with Freezing of gait in Parkinson's disease using transfer entropy analysis.
    Brain Res. 2023 Sep 30:148610. doi: 10.1016/j.brainres.2023.148610.
    PubMed     Abstract available
    
    
    
53. CABRAL LM, Oliveira LM, Miranda NC, Kawamoto EM, et al
    TNFR1-mediated neuroinflammation is necessary for respiratory deficits observed in 6-hydroxydopamine mouse model of Parkinsons Disease.
    Brain Res. 2023 Sep 25:148586. doi: 10.1016/j.brainres.2023.148586.
    PubMed     Abstract available
    
    
    
54. SONG J, Zhao Y, Shan X, Luo Y, et al
    Active ingredients of Chinese medicine with immunomodulatory properties: NF-kappaB pathway and Parkinson's disease.
    Brain Res. 2023 Sep 23:148603. doi: 10.1016/j.brainres.2023.148603.
    PubMed     Abstract available
    
    
    August 2023
55. UNAL I, Cansiz D, Beler M, Sezer Z, et al
    Sodium-dependent Glucose Co-Transporter-2 Inhibitor Empagliflozin Exerts Neuroprotective Effects in Rotenone-Induced Parkinson's Disease Model in Zebrafish; Mechanism Involving Ketogenesis and Autophagy.
    Brain Res. 2023 Aug 15:148536. doi: 10.1016/j.brainres.2023.148536.
    PubMed     Abstract available
    
    
    June 2023
56. KHOT M, Sood A, Pushpa Tryphena K, Pinjala P, et al
    Dimethyl fumarate ameliorates Parkinsonian pathology by modulating autophagy and apoptosis via Nrf2-TIGAR-LAMP2/Cathepsin D axis.
    Brain Res. 2023 Jun 12:148462. doi: 10.1016/j.brainres.2023.148462.
    PubMed     Abstract available
    
    
    
57. RAI P, Ratnaparkhi A, Kumar Roy J
    Rab11 rescues muscle degeneration and synaptic morphology in the park(13/+) Parkinson model of Drosophila melanogaster.
    Brain Res. 2023 Jun 9:148442. doi: 10.1016/j.brainres.2023.148442.
    PubMed     Abstract available
    
    
    
58. OLIVEIRA LM, Severs L, Moreira TS, Ramirez JM, et al
    Ampakine CX614 increases respiratory rate in a mouse model of Parkinson's disease.
    Brain Res. 2023;1815:148448.
    PubMed     Abstract available
    
    
    
59. ZHOU W, He J, Zhang C, Pan Y, et al
    Fiber-specific white matter alterations in Parkinson's disease patients with freezing of gait.
    Brain Res. 2023 Jun 2:148440. doi: 10.1016/j.brainres.2023.148440.
    PubMed     Abstract available
    
    
    May 2023
60. HENRIQUE BINDA K, Landau AM, Chacur M, Brooks DJ, et al
    Treadmill exercise modulates nigral and hippocampal cannabinoid receptor type 1 in the 6-OHDA model of Parkinson's disease.
    Brain Res. 2023 May 31:148436. doi: 10.1016/j.brainres.2023.148436.
    PubMed     Abstract available
    
    
    
61. ROUZITALAB A, Boulay CB, Sachs AJ
    Volitional Control of Beta Activities in Parkinson's Disease Patients.
    Brain Res. 2023 May 6:148394. doi: 10.1016/j.brainres.2023.148394.
    PubMed     Abstract available
    
    
    April 2023
62. CONTI MAZZA MM, Centner A, Werner DF, Bishop C, et al
    Striatal serotonin transporter gain-of-function in L-DOPA-treated, hemi-parkinsonian rats.
    Brain Res. 2023 Apr 29:148381. doi: 10.1016/j.brainres.2023.148381.
    PubMed     Abstract available
    
    
    March 2023
63. BOSCH TJ, Espinoza AI, Singh A
    Cerebellar oscillatory dysfunction during lower-limb movement in Parkinson's disease with freezing of gait.
    Brain Res. 2023;1808:148334.
    PubMed     Abstract available
    
    
    
64. NING B, Wang Z, Wu Q, Deng Q, et al
    Acupuncture inhibits autophagy and repairs synapses by activating the mTOR pathway in Parkinson's disease depression model rats.
    Brain Res. 2023 Mar 11:148320. doi: 10.1016/j.brainres.2023.148320.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Parkinson's Disease is free of charge.